Concepedia

Andrius Žučenka

AŽ

9

Publications

140

Citations

9

H-Index

2019

Active since

Affiliations

Vilnius University(Current)

Memorial Sloan Kettering Cancer Center

Vilnius University Hospital Santariskiu Klinikos

The University of Texas MD Anderson Cancer Center

Emory University

Andrius Žučenka is an author at Vilnius University specializing in oncology, hematology, and medicine.

ORCID

Top concepts

Publications per year

2019–2025

9

Publications

9

Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation

Andrius Žučenka, Vilmantė Vaitekėnaitė, Kazimieras Maneikis et al. · Bone Marrow Transplantation · 2021 · 23 citations

, , +10

Menin inhibition with revumenib for <i>NPM1</i>-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

Martha Arellano, Michael J. Thirman, John F. DiPersio et al. · Blood · 2025 · 23 citations · Full text

Revumenib Maintenance Therapy Following Revumenib-Induced Remission and Transplant

Andrius Žučenka, Ghayas C. Issa, Martha Arellano et al. · Blood · 2023 · 20 citations

Oxidative phosphorylation inhibition induces anticancerous changes in therapy‐resistant–acute myeloid leukemia patient cells

Aida Vitkevičienė, Vytautas Janulis, Andrius Žučenka et al. · Molecular Carcinogenesis · 2019 · 16 citations

HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia

Aida Vitkevičienė, Giedrė Skiauterytė, Andrius Žučenka et al. · Journal of Oncology · 2019 · 13 citations · Full text

Rows per page

1–5 of 9